The combination of an inclusive novel agent treatment strategy, pre-emptive therapy dose reduction, and prolonged therapy results in good outcomes in elderly myeloma patients

Br J Haematol. 2019 Aug;186(3):e11-e13. doi: 10.1111/bjh.15848. Epub 2019 Mar 12.
No abstract available

Keywords: dose reduction; elderly; myeloma; novel agent; overall survival.

Publication types

  • Letter

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Multiple Myeloma / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents